Dexcom Inc Stock Investor Sentiment
| DXCM Stock | USD 78.10 0.16 0.21% |
About 53% of DexCom's investor base is interested to short. The analysis of overall sentiment of trading DexCom Inc stock suggests that many investors are impartial at this time. DexCom's investing sentiment overview a quick insight into current market opportunities from investing in DexCom Inc. Many technical investors use DexCom Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
47
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use DexCom's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward DexCom Inc.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
DexCom Historical Sentiment
Although DexCom's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding DexCom, such as negative comments on social media and news outlets, may cause fear in the market and push DexCom's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of DexCom.
DexCom |
DexCom Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards DexCom can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
DexCom Inc Historical Investor Sentiment
Investor biases related to DexCom's public news can be used to forecast risks associated with an investment in DexCom. The trend in average sentiment can be used to explain how an investor holding DexCom can time the market purely based on public headlines and social activities around DexCom Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
DexCom's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for DexCom and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average DexCom news discussions. The higher the estimate score, the more favorable the investor's outlook on DexCom.
Far too much social signal, news, headlines, and media speculation about DexCom that are available to investors today. That information is available publicly through DexCom media outlets and privately through word of mouth or via DexCom internal channels. However, regardless of the origin, that massive amount of DexCom data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DexCom news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DexCom relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DexCom's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DexCom alpha.
DexCom Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | DexCom Non-GAAP EPS of 0.45 beats by 0.02, revenue of 994.2M beats by 3.01M | 10/24/2024 |
2 | Are Investors Undervaluing DexCom, Inc. By 44 | 11/08/2024 |
3 | Disposition of 3500 shares by Jereme Sylvain of DexCom at 75.51 subject to Rule 16b-3 | 11/15/2024 |
4 | Dexcom and URA Announce Strategic Partnership | 11/19/2024 |
5 | Disposition of 4259 shares by Sadie Stern of DexCom at 74.73 subject to Rule 16b-3 | 11/20/2024 |
6 | Disposition of 652 shares by Michael Brown of DexCom at 69.55 subject to Rule 16b-3 | 11/21/2024 |
7 | Dexcoms chief HR officer Sadie Stern sells shares worth 318,275 | 11/22/2024 |
8 | BofA reaffirms buy rating on DexCom shares, sees potential for growth | 11/25/2024 |
9 | DexCom, Inc. Shares Bought by Qsemble Capital Management LP | 11/26/2024 |
Check out DexCom Hype Analysis, DexCom Correlation and DexCom Performance. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.157 | Earnings Share 1.65 | Revenue Per Share 10.089 | Quarterly Revenue Growth 0.02 | Return On Assets 0.0606 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.